“…However, despite a great diversity offering a strong potential for innovation, only a few of them—namely xanthan, gellan, hyaluronic acid, welan, clavan, fucopol, pullulan and dextran—are currently marketed [ 2 , 3 , 4 ]. Given the knowledge on polysaccharide synthetic pathways as well as the huge amount of available enzyme sequences and the progress made in protein and metabolic engineering, the supply of enzymatically or microbiologically produced polysaccharides, shaped on demand, is expected to rise significantly [ 5 , 6 ].…”